Buprenorphine and pain treatment in pediatric patients: an update
Open Access
- 1 March 2018
- journal article
- research article
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 11, 549-559
Abstract
Introduction: The usual management of moderate to severe pain is based on the use of opioids. Buprenorphine (BPN) is an opioid with an analgesic potency 50 times greater than that of morphine. It is widely used in various pain models and has demonstrated efficacy and safety in adult patients; however, there are insufficient clinical trials in pediatric populations. Purpose: The aim of this study was to perform an updated meta-analysis on the implementation of BPN in the treatment of pain in the pediatric population. Methods: A bibliographic search was carried out in different biomedical databases to identify scientific papers and clinical trials with evidence of BPN use in children and adolescents. Results: A total of 89 articles were found, of which 66 were selected. Analysis of these items revealed additional sources, and the final review included a total of 112 publications. Conclusion: Few studies were found regarding the efficacy and safety of BPN use in children. In recent years, the use of this drug in the pediatric population has become widespread, so it is imperative to perform clinical trials and pharmacological and pharmacovigilance studies, which will allow researchers to develop dosage schemes based on the evidence and minimize the risk of adverse effects.Keywords
This publication has 94 references indexed in Scilit:
- Buprenorphine Metabolites, Buprenorphine-3-glucuronide and Norbuprenorphine-3-glucuronide, Are Biologically ActiveAnesthesiology, 2011
- 2010 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 28th Annual ReportClinical Toxicology, 2011
- Pediatric Palliative CarePediatric Drugs, 2009
- Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)Pain Practice, 2008
- Exploratory Buprenorphine Ingestion in an InfantAnnals of Emergency Medicine, 2006
- Buprenorphine: Considerations for Pain ManagementJournal of Pain and Symptom Management, 2005
- Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic μ opioid and ORL1 receptor G protein couplingDevelopmental Brain Research, 2004
- Transdermal BuprenorphineDrugs, 2003
- Buprenorphine in a Transdermal Therapeutic System – A New OptionClinical Rheumatology, 2002
- BuprenorphineDrugs, 1979